Viewing StudyNCT00045396

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00045396
Status: COMPLETED
Last Update Posted: 2013-01-09
First Post: 2002-09-06
Brief Title: A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA R115777 NSC 702818 IND 58359 In Complete Remission Following Induction AndOr Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia AML And High-Risk Myelodysplasia MDS
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Adult Acute Myeloid Leukemia in Remission
Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities
Adult Acute Myeloid Leukemia With Del5q
Adult Acute Myeloid Leukemia With Inv16p13q22
Adult Acute Myeloid Leukemia With t1517q22q12
Adult Acute Myeloid Leukemia With t1616p13q22
Adult Acute Myeloid Leukemia With t821q22q22
de Novo Myelodysplastic Syndromes
Secondary Myelodysplastic Syndromes
Keywords: